• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Managing post-stroke care during the COVID-19 pandemic at a tertiary care level hospital in Peru
Objectives: To understand the hospital-to-outpatient care transition and how the discharge process of stroke patients is managed; and to identify potential opportunities to improve these processes, while contrasting pre- and during COVID-19 experiences in Peru.Methods: A qualitative study was conducted between February and March 2021 consisting of in-depth interviews of patients with stroke, their caregivers and healthcare personnel regarding stroke care at a national tertiary referral center for stroke care in Lima, Peru.
Source: Journal of Stroke and Cerebrovascular Diseases - December 23, 2021 Category: Neurology Authors: Jessica Hanae Zafra-Tanaka, Jill Portocarrero, Carlos Abanto, Joseph R. Zunt, J. Jaime Miranda Source Type: research

Adherence to American Heart Association/American Stroke Association Clinical Performance Measures in a Peruvian Neurological Reference Institute
Little is known about adherence to American Heart Association/American Stroke Association (AHA/ASA) stroke performance measures in developing countries like Peru.
Source: Journal of Stroke and Cerebrovascular Diseases - September 9, 2020 Category: Neurology Authors: Carlos Abanto, Angela K. Ulrich, Ana Valencia, V íctor Dueñas, Silvia Montano, David Tirschwell, Joseph Zunt Source Type: research

Challenges of Thrombolysis in a Developing Country: Characteristics and Outcomes in Peru
Background: The availability of intravenous tissue plasminogen activator (IV-tPA) remains limited worldwide, especially in low-income countries, where the burden of disability due to ischemic stroke is the highest. Aims: To evaluate outcomes and safety of IV-tPA at the only Peruvian reference institute for neurologic diseases. Methods: We conducted a prospective, observational study of stroke patients who received IV-tPA between 2009 and 2016. We assessed characteristics associated with good outcome (modified Rankine scale 0-2) at 3 months using a multivariate regression model; and factors correlated with clinical improvem...
Source: Journal of Stroke and Cerebrovascular Diseases - April 15, 2020 Category: Neurology Authors: Carlos Abanto, Ana Valencia, Pilar Calle, Danny Barrientos, N éstor Flores, María Novoa, Rosa L. Ecos, Jorge Alonso Ramirez, Angela K. Ulrich, Joseph R. Zunt, David L. Tirschwell, Sarah Wahlster Source Type: research

A Novel Variant in Non-coding Region of GJB1 Is Associated With X-Linked Charcot-Marie-Tooth Disease Type 1 and Transient CNS Symptoms
Conclusion A novel GJB1 variant of c.-170T>G in non-coding region was found in this big Chinese CMTX1 pedigree. This is the first report of variant in non-coding DNA sequence associated with transient CNS symptoms. Thyroid malfunction may contribute to the CNS symptoms in this case. Ethics Statement This study has been reviewed and approved by the Ethics Committee of the China-Japan Union Hospital of Jilin University. Each member of the family provided written informed consent to the participation in the study, the genetic test, and authorized to publish the study including the photos in accordance with the Decl...
Source: Frontiers in Neurology - April 23, 2019 Category: Neurology Source Type: research

Role of mHealth in overcoming the occurrence of post ‐stroke depression
This article proposes the rationale for a suitable evidence‐driven, mHealth‐based, PSD self‐management intervention called iMOODS—Investigating the role of mHealth in overcoming occurrence of depression after stroke—that could be tested among recent stroke patients with PSD in resource constrained settings.
Source: Acta Neurologica Scandinavica - September 13, 2017 Category: Neurology Authors: J. J. Miranda, M. G. Moscoso, M. Toyama, V. Cavero, F. Diez ‐Canseco, B. Ovbiagele Tags: REVIEW ARTICLE Source Type: research

Predictors of Functional Outcome among Stroke Patients in Lima, Peru
Conclusions: Favorable outcome after stroke was independently associated with younger age, a lower NIHSS score, male gender, being divorced, and not being on SIS insurance. These findings suggest that additional study of worse functional outcomes in patients with SIS insurance be conducted and confirm the importance of risk adjustment for age, stroke severity (according to the NIHSS scale), and other socioeconomic factors in outcomes studies. Future studies should preferentially assess outcome at 30 days and 6 months to provide more reliable comparisons and allow additional study of Peruvian end-of-life decision-making and care.
Source: Journal of Stroke and Cerebrovascular Diseases - January 24, 2013 Category: Neurology Authors: Carlos Abanto, Thanh G.N. Ton, David L. Tirschwell, Silvia Montano, Yrma Quispe, Isidro Gonzales, Ana Valencia, Pilar Calle, Arturo Garate, Joseph Zunt Tags: Original Articles Source Type: research